Clinical trials in Sevilla – page 44

1 637 clinical trials in Sevilla, Spain across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SpainEnsayosClinicos.es

Sevilla at a glance

1 637

clinical trials

Research sites4

Quick filters

1 637 trials in Sevilla

Open in trial search

Haematological malignancy+1

Recruiting

Study on the Safety of CA-4948 and Ibrutinib for Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Registered drugNo placebo

Study on the Safety of CA-4948 and Ibrutinib for Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Emavusertib
Sponsor:Curis Inc.

Contact Research Centre

Migraine+2

Recruiting

Study on Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years

Registered drug

Study on Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years

Registered drug

Spain

Participants:0–17 years
Substances:Rimegepant
Sponsor:Pfizer Inc.

Contact Research Centre

Micrographic skin surgery

Recruiting

Study on Autologous Skin-Derived Keratinocytes and Fibroblasts for Patients with Basal Cell Carcinoma Undergoing Reconstructive Surgery

InvestigationalNo placebo

Study on Autologous Skin-Derived Keratinocytes and Fibroblasts for Patients with Basal Cell Carcinoma Undergoing Reconstructive Surgery

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Skin Autograft
Sponsor:Red Andaluza De Diseno Y Traslacion De Terapias Avanzadas Fundacion Publica Andaluza Progreso Y Salud

Contact Research Centre

Plasma cell myeloma+3

Recruiting

Long-Term Follow-Up Study for Patients with Myxoid/Round Cell Liposarcoma, Multiple Myeloma, Non-Small Cell Lung Cancer, or Synovial Sarcoma Treated with Letetresgene Autoleucel

InvestigationalNo placebo

Long-Term Follow-Up Study for Patients with Myxoid/Round Cell Liposarcoma, Multiple Myeloma, Non-Small Cell Lung Cancer, or Synovial Sarcoma Treated with Letetresgene Autoleucel

InvestigationalNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Letetresgene Autoleucel
Sponsor:USWM Ct LLC

Contact Research Centre

Hepatotoxicity

Recruiting

Study on the Effectiveness and Safety of Prednisone for Patients with Drug-Induced Liver Injury (DILI)

Registered drug

Study on the Effectiveness and Safety of Prednisone for Patients with Drug-Induced Liver Injury (DILI)

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Prednisone
Sponsor:Fundacion Publica Andaluza Para La Investigacion De Malaga En Biomedicina Y Salud

Contact Research Centre

Lupus nephritis

Recruiting

Study on the Effectiveness and Safety of Iptacopan with Drug Combination for Adults with Active Lupus Nephritis Class III-IV, +/- V

Registered drug

Study on the Effectiveness and Safety of Iptacopan with Drug Combination for Adults with Active Lupus Nephritis Class III-IV, +/- V

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Iptacopan
Sponsor:Novartis Pharma AG

Contact Research Centre

Behcet's syndrome

Recruiting

Study on Apremilast for Treating Oral Ulcers in Children with Behçet's Disease

Investigational

Study on Apremilast for Treating Oral Ulcers in Children with Behçet's Disease

Investigational

Spain

Participants:0–17 years
Substances:Apremilast
Sponsor:Amgen Inc.

Contact Research Centre

Chronic fatigue syndrome+1

Recruiting

Study on Safinamide and Rasagiline for Treating Fatigue in Parkinson's Disease Patients on Stable Dopaminergic Treatment

Registered drugNo placebo

Study on Safinamide and Rasagiline for Treating Fatigue in Parkinson's Disease Patients on Stable Dopaminergic Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Rasagiline
Sponsor:Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau

Contact Research Centre

Myasthenia gravis

Recruiting

Study on Nipocalimab for Adults with Generalized Myasthenia Gravis

Investigational

Study on Nipocalimab for Adults with Generalized Myasthenia Gravis

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Nipocalimab
Sponsor:Janssen Cilag International

Contact Research Centre

Glomerulonephritis membranoproliferative

Recruiting

Study on the Effects of Iptacopan in Patients with Idiopathic Membranoproliferative Glomerulonephritis (IC-MPGN)

Investigational

Study on the Effects of Iptacopan in Patients with Idiopathic Membranoproliferative Glomerulonephritis (IC-MPGN)

Investigational

Spain

Participants:0–17 years · 18–64 years
Substances:Iptacopan
Sponsor:Novartis Pharma AG

Contact Research Centre

Adenocarcinoma of colon

Recruiting

Study of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer

Registered drugNo placebo

Study of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Glaxosmithkline Research & Development Limited

Contact Research Centre

Dementia Alzheimer's type

Recruiting

Study on the Effects of Rotigotine and Rivastigmine in Patients with Mild to Moderate Alzheimer's Disease

Registered drug

Study on the Effects of Rotigotine and Rivastigmine in Patients with Mild to Moderate Alzheimer's Disease

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Rotigotine
Sponsor:Fondazione Santa Lucia

Contact Research Centre

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Sevilla

What the registry says about research in the country

01 Metabolic and Endocrine Disorders

Innovative research focusing on Type 1 Diabetes management and weight-related conditions, evaluating new therapeutic approaches for glycemic control and metabolic health.

Diabetes Management
Obesity Treatment
Metabolic Disorders

Studies aim to improve treatment outcomes for patients with complex metabolic conditions.

02 Neurological Conditions

Advanced clinical trials examining treatments for Multiple Sclerosis and neurodegenerative disorders, including pioneering research in Frontotemporal Dementia and Parkinson's disease.

Multiple Sclerosis Therapies
Neurodegenerative Diseases
Brain Health Innovation

Research focuses on developing targeted treatments for various neurological conditions.

03 Infectious Diseases

Comprehensive vaccine development programs targeting Influenza, Cytomegalovirus, and meningococcal infections, with emphasis on preventive medicine.

Vaccine Development
Viral Infections
Immunization Studies

Studies aim to enhance vaccine efficacy and immune response across different age groups.

04 Oncology Research

Groundbreaking studies in cancer treatment, including research on bladder cancer and mantle cell lymphoma, exploring combination therapies and targeted treatments.

Cancer Immunotherapy
Targeted Therapies
Combination Treatments

Focus on developing innovative approaches to improve cancer treatment outcomes.

05 Autoimmune Conditions

Clinical investigations into Psoriatic Arthritis and inflammatory conditions, evaluating novel therapeutic approaches and treatment combinations.

Arthritis Treatment
Inflammatory Diseases
Immune System Disorders

Research aims to develop more effective treatments for chronic autoimmune conditions.

Back to Spain All countries